Body Mass Index Modulates the Impact of Short-Term Exposure to Air Particulate Matter on High-Density Lipoprotein Function.

air pollution body mass index endothelium high-density lipoproteins nitric oxide

Journal

Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981

Informations de publication

Date de publication:
28 Sep 2022
Historique:
received: 30 08 2022
revised: 19 09 2022
accepted: 24 09 2022
entrez: 27 10 2022
pubmed: 28 10 2022
medline: 28 10 2022
Statut: epublish

Résumé

Air particulate matter (PM) exposure has been associated with increased cardiovascular risk, especially in obesity. By triggering inflammation and oxidative stress, PM could impact atheroprotection by high-density lipoproteins (HDL). The aim of the study was to assess the relationship between short-term exposure to PM and HDL function, and the modifying effect of body mass index (BMI). Daily exposures to PM10 and PM2.5 of 50 subjects with overweight/obesity and 41 healthy volunteers with BMI < 30 kg/m2 were obtained from fixed monitoring stations. HDL function was assessed as promotion of nitric oxide (NO) release by endothelial cells and reduction in cholesterol in macrophages. HDL-induced NO release progressively declined with the increase in BMI. No association was found between HDL function and PM exposure, but a modifying effect of BMI was observed. The positive association between PM10 exposure at day −1 and NO production found at normal BMI values was lost in participants with higher BMI. Similar results were obtained for the reduction in macrophage cholesterol. The loss of the compensatory response of HDL function to PM exposure at increasing BMI levels could contribute to the endothelial dysfunction induced by PM and help to explain the susceptibility of subjects with obesity to air pollution.

Identifiants

pubmed: 36290661
pii: antiox11101938
doi: 10.3390/antiox11101938
pmc: PMC9598765
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : University of Milan
ID : PSR2019 Linea 2 Azione A
Organisme : European Research Council
ID : ERC-2011-StG 282413
Pays : International

Références

Toxicol Lett. 2012 Nov 15;214(3):263-7
pubmed: 22982457
Environ Pollut. 2022 Jan 1;292(Pt A):118247
pubmed: 34624398
Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):513-522
pubmed: 30700134
Hypertension. 2013 Aug;62(2):352-8
pubmed: 23798345
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Am J Epidemiol. 2008 Dec 15;168(12):1397-408
pubmed: 18952849
Part Fibre Toxicol. 2020 Aug 4;17(1):36
pubmed: 32753036
Pharmacol Ther. 2006 Sep;111(3):836-54
pubmed: 16960983
Curr Med Chem. 2019;26(9):1610-1630
pubmed: 29546829
Eur Heart J. 2018 Oct 7;39(38):3543-3550
pubmed: 30124840
Environ Res. 2017 May;155:228-234
pubmed: 28231550
Arterioscler Thromb Vasc Biol. 2003 Oct 1;23(10):1724-31
pubmed: 12969988
Circulation. 2005 Dec 20;112(25):3930-6
pubmed: 16365212
J Intern Med. 2022 Jun;291(6):779-800
pubmed: 35138681
Atherosclerosis. 2009 Aug;205(2):506-11
pubmed: 19200546
Atherosclerosis. 2020 Mar;297:8-15
pubmed: 32058863
Part Fibre Toxicol. 2017 Aug 24;14(1):32
pubmed: 28899404
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1722-9
pubmed: 23885040
Heart. 2022 Jul 27;108(16):1267-1273
pubmed: 35074847
Circulation. 2011 Apr 26;123(16):1721-8
pubmed: 21482966
Am J Cardiol. 2018 Aug 15;122(4):565-570
pubmed: 30005891
BMC Public Health. 2014 Nov 04;14:1137
pubmed: 25371091
Circulation. 2004 Jun 1;109(21):2655-71
pubmed: 15173049
Eur Heart J. 2020 Jan 1;41(1):111-188
pubmed: 31504418
Part Fibre Toxicol. 2015 Mar 19;12:6
pubmed: 25890359
J Am Heart Assoc. 2021 May 18;10(10):e018448
pubmed: 33942621
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326

Auteurs

Alice Ossoli (A)

Center E. Grossi Paoletti, Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milan, Italy.

Chiara Favero (C)

EPIGET Lab, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, 20122 Milan, Italy.

Luisella Vigna (L)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Angela Cecilia Pesatori (AC)

EPIGET Lab, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, 20122 Milan, Italy.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Valentina Bollati (V)

EPIGET Lab, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, 20122 Milan, Italy.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Monica Gomaraschi (M)

Center E. Grossi Paoletti, Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milan, Italy.

Classifications MeSH